AbbVie Inc. (ABBV)
NYSE: ABBV · Real-Time Price · USD
201.31
-7.86 (-3.76%)
At close: Mar 25, 2025, 4:00 PM
201.40
+0.09 (0.04%)
After-hours: Mar 25, 2025, 7:39 PM EST
AbbVie Stock Forecast
Stock Price Forecast
The 20 analysts with 12-month price forecasts for AbbVie stock have an average target of 212.7, with a low estimate of 185 and a high estimate of 240. The average target predicts an increase of 5.66% from the current stock price of 201.31.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for AbbVie stock from 21 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
---|---|---|---|---|---|---|
Strong Buy | 8 | 9 | 8 | 8 | 8 | 8 |
Buy | 9 | 11 | 11 | 11 | 10 | 10 |
Hold | 3 | 2 | 3 | 3 | 3 | 3 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 20 | 22 | 22 | 22 | 21 | 21 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Wells Fargo | Wells Fargo | Buy Maintains $210 → $240 | Buy | Maintains | $210 → $240 | +19.22% | Mar 5, 2025 |
B of A Securities | B of A Securities | Hold Maintains $200 → $223 | Hold | Maintains | $200 → $223 | +10.77% | Mar 4, 2025 |
Citigroup | Citigroup | Strong Buy Maintains $205 → $215 | Strong Buy | Maintains | $205 → $215 | +6.80% | Feb 3, 2025 |
Truist Securities | Truist Securities | Strong Buy Maintains $211 → $217 | Strong Buy | Maintains | $211 → $217 | +7.79% | Feb 3, 2025 |
UBS | UBS | Hold Maintains $181 → $190 | Hold | Maintains | $181 → $190 | -5.62% | Feb 3, 2025 |
Financial Forecast
Revenue This Year
60.69B
from 56.33B
Increased by 7.74%
Revenue Next Year
65.56B
from 60.69B
Increased by 8.02%
EPS This Year
12.52
from 2.39
Increased by 424.01%
EPS Next Year
14.23
from 12.52
Increased by 13.59%
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 63.6B | 70.0B | 75.0B | ||
Avg | 60.7B | 65.6B | 70.1B | ||
Low | 57.8B | 61.4B | 65.6B |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 12.9% | 15.3% | 14.4% | ||
Avg | 7.7% | 8.0% | 6.9% | ||
Low | 2.6% | 1.2% | 0.0% |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 13.30 | 15.71 | 17.90 | ||
Avg | 12.52 | 14.23 | 15.86 | ||
Low | 11.77 | 12.59 | 13.85 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 456.6% | 25.4% | 25.8% | ||
Avg | 424.0% | 13.6% | 11.5% | ||
Low | 392.5% | 0.6% | -2.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.